These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 6864687

  • 1. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS, Prince RK, Buckingham RB, Rodnan GP.
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [Abstract] [Full Text] [Related]

  • 2. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
    Buckingham RB, Prince RK, Rodnan GP.
    J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
    [Abstract] [Full Text] [Related]

  • 3. Progressive systemic sclerosis and penicillamine.
    Rodnan GP.
    J Rheumatol Suppl; 1981 May; 7():116-20. PubMed ID: 6939873
    [Abstract] [Full Text] [Related]

  • 4. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA, Sigal SH.
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [Abstract] [Full Text] [Related]

  • 5. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J.
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [Abstract] [Full Text] [Related]

  • 6. Penicillamine therapy in systemic sclerosis.
    Jayson MI, Lovell C, Black CM, Wilson RS.
    Proc R Soc Med; 1977 Mar; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [Abstract] [Full Text] [Related]

  • 7. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
    Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, Birembaut P, Maquart FX.
    Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
    [Abstract] [Full Text] [Related]

  • 8. Activation of dermal connective tissue in scleroderma.
    Kähäri VM.
    Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
    [Abstract] [Full Text] [Related]

  • 9. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G.
    Acta Derm Venereol; 1975 Dec; 55(6):461-5. PubMed ID: 55038
    [Abstract] [Full Text] [Related]

  • 10. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
    Soria A, Cario-André M, Lepreux S, Rezvani HR, Pasquet JM, Pain C, Schaeverbeke T, Mahon FX, Taïeb A.
    Dermatology; 2008 Dec; 216(2):109-17. PubMed ID: 18216472
    [Abstract] [Full Text] [Related]

  • 11. [Systemic sclerosis].
    Gustafsson R.
    Nord Med; 1994 Dec; 109(8-9):236-7. PubMed ID: 7937033
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A, Pavelka K, Kludas M.
    Munch Med Wochenschr; 1969 Aug 01; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract] [Full Text] [Related]

  • 13. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN, Krel' AA, Shekhter AB, Rashchupkina ZP.
    Klin Med (Mosk); 1982 Jan 01; 60(1):77-82. PubMed ID: 7078046
    [No Abstract] [Full Text] [Related]

  • 14. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
    Pasquali Ronchetti I, Guerra D, Quaglino D, Vincenzi D, Manzini E, Canossi B, Manzini CU.
    Clin Exp Rheumatol; 1989 Jan 01; 7(4):373-83. PubMed ID: 2591110
    [Abstract] [Full Text] [Related]

  • 15. Treatment of systemic sclerosis.
    Medsger TA.
    Rheum Dis Clin North Am; 1989 Aug 01; 15(3):513-31. PubMed ID: 2672135
    [Abstract] [Full Text] [Related]

  • 16. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 1999 Jun 01; 42(6):1194-203. PubMed ID: 10366112
    [Abstract] [Full Text] [Related]

  • 17. Changes in the growth and metabolism of cells cultured from normal, sclerotic and rheumatoid connective tissue brought about by D-penicillamine and by sodium salicylate.
    Priestley GC.
    J Invest Dermatol; 1980 Jun 01; 74(6):413-7. PubMed ID: 6445922
    [Abstract] [Full Text] [Related]

  • 18. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).
    Buckingham RB, Prince RK, Rodnan GP, Taylor F.
    J Lab Clin Med; 1978 Jul 01; 92(1):5-21. PubMed ID: 351108
    [No Abstract] [Full Text] [Related]

  • 19. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF, Manzato LC, Samara AM.
    AMB Rev Assoc Med Bras; 1980 Jun 01; 26(6):191-3. PubMed ID: 6970374
    [No Abstract] [Full Text] [Related]

  • 20. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J, Helin P, Rasmussen O, Lorenzen I.
    Ann Clin Res; 1970 Sep 01; 2(3):228-34. PubMed ID: 5473163
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.